Phase II study of nilotinib plus pegylated interferon alfa-2b as first-line therapy in chronic phase chronic myeloid leukaemia aiming to maximize complete molecular response and major molecular response (CML11)
收藏DataCite Commons2024-07-11 更新2024-07-13 收录
下载链接：
https://www.allg.org.au/datasets/cml11/
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
提供机构：
Australasian Leukaemia and Lymphoma Group (ALLG)
创建时间：
2023-06-08
